Hartalega Holdings, a Malaysian maker of nitrile gloves, reported on 12 November 2026 that profit after tax for the three months to 30 September rose 83.3% from a year earlier to RM32.8 million, on revenue up 19.5% at RM644.7 million. In the same filing to Bursa Malaysia, the Kuala Lumpur stock exchange, the company said higher US tariffs on gloves made in China were improving the position of Malaysian producers in the United States, while redirected Chinese supply was intensifying competition outside the United States.1
What the company told the exchange
Hartalega said the revenue growth came from higher average selling prices, with sales volume "broadly stable". It linked the price rises to the cost of nitrile, a synthetic rubber, which it said rose significantly during the Middle East conflict, and added that the cost increases were not fully passed on to customers.1
The tariff passage is in the section on prospects:
Higher US tariffs have increased the costs of China-origin gloves in the US, thereby enhancing the competitiveness of Malaysian producers.1
The same paragraph sets out the other side. Hartalega wrote that global manufacturing capacity "continues to exceed demand, limiting industry pricing power", that redirected Chinese supply "continues to intensify competition in non-US markets", and that the expansion of China-owned factories in South East Asia "could further heighten competitive pressures in the US market".1
The quarter was weaker than the one before it. Operating profit fell 49.5% from the April to June quarter, to RM40.4 million from RM80.0 million, and the operating margin fell to 6.3% from 13.2%. The filing puts this mainly on a sharp drop in selling prices late in the quarter that could not offset high raw material costs.1
Utusan Malaysia, a Malay-language daily, reported a statement by the chief executive, Kuan Mun Leong, in which he said the tariffs on Chinese-made gloves and the company's ties with existing American customers gave it an advantage in raising sales there. The paper gave the group's net cash as RM1.19 billion at 30 September.2
A US tariff on Chinese gloves
Hartalega's filing does not name the tariffs it means. Section 301 of the US Trade Act of 1974 allows duties on a country's goods after an investigation of its trade practices. In a notice published on 18 September 2024, the US Trade Representative set the additional Section 301 duty on Chinese medical or surgical gloves of vulcanised rubber at 50% in 2025 and 100% in 2026. This article did not check whether that schedule was later changed. The notice records that some commenters argued glove production was concentrated in China and Malaysia and that the duties would move production to Malaysia, not to the United States. The Trade Representative replied that it expected more supply from American and third-country sources.3
Malaysian goods are not free of US tariffs. The Trade Representative said on 23 July 2026 that 10% was the rate of Section 301 duty for a group of economies that includes Malaysia, in its investigation of forced-labour import bans, with exemptions for certain Malaysian products. The release does not name gloves. The notice it links to imposes 10% on products of Malaysia except those in its annexes; a text search of that pre-publication notice for this article found no rubber-glove tariff line (heading 4015) among the exemptions.4 10
Top Glove: North American volume up 41%
Top Glove, which calls itself the world's largest rubber glove manufacturer, filed its results for the year to 31 August 2026 on 6 October. Profit attributable to shareholders was RM307.96 million, against RM105.33 million a year earlier, on revenue of RM4.23 billion, against RM3.49 billion.5 6
Sin Chew Daily, a Chinese-language Malaysian newspaper whose report is reproduced on Top Glove's website, quoted the company as saying that in 2026 its sales volume rose 41% in North America and 43% in Asia and fell 8% in the Middle East. The Edge, a Malaysian business weekly, reported the executive chairman, Lim Wee Chai, as saying at the results briefing that Top Glove's costs and prices were now very close to those of Chinese makers. "Competition is there, but not as tough as two, three years ago," he said.6 7
What the trade figures and the Chinese side say
Malaysia's official export figures do not show the same gain. The trade ministry told parliament in a written answer that Malaysian rubber glove exports to the United States fell 1.6% to RM5.0 billion in January to September 2026, according to a Bernama report carried by Utusan Malaysia. That figure is a value in ringgit for the whole industry, and Hartalega's own filing says a stronger ringgit reduced the ringgit value of its sales, so it cannot be set directly against one company's sales volume.8 1
Intco Medical, a listed Chinese glove maker, described the market differently from Hartalega when it met investors on 28 October 2026. It reported revenue of 10.619 billion yuan for the first nine months of 2026, up 43.02%, and said its November orders were full.9
目前行业无批量在建待投产产能,此前马来西亚友商官宣永久退出,中小老旧产能受原材料涨价、现金流等因素影响持续出清,公司按计划稳步扩产,并且满产满销。
The industry at present has no large batch of capacity under construction and waiting to start; a Malaysian peer earlier announced its permanent exit, small and old capacity keeps being cleared out by raw material price rises and cash-flow pressure, and the company is expanding steadily as planned, with full production and full sales.9
Intco did not name the Malaysian company. Asked for its view on European tariffs, it said new European duties on disposable gloves were unlikely in the short term and that it would adjust the pace of its expansion to any tariff.9
Top Glove's final dividend is payable on 15 December 2026. The documents read for this article do not give either Malaysian company's sales to the United States as a share of its total, and Hartalega's filing leaves open how far Chinese-owned plants in South East Asia will supply the American market.6 1